Delivery Order SPE2DB24D1007-SPE2DB24FBZCF
Award Date 4/12/24
Potential Completion Date 4/15/24
Potential Value $8.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, a firm fixed price delivery order contract for HUMIRA(CF) 40 MG/0.4 ML syringes. The $1,847.20 contract has a completion date of February 13, 2024 and does not utilize any set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,847.20 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply HUMIRA 40 MG/0.8 ML SYRINGES. This award is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes. The potential value of this contract is $6,597.12, with a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563652747 HUMIRA(CF) 40 MG/0.4 ML SYRINGES. The contract has a completion date of February 14, 2024 and a potential value of $1,847.20. Amerisourcebergen Drug Corp is the prime contractor on this award and does not have any major subcontractors listed. This delivery order is part of a larger indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) 20 MG/0.2 ML syringes. The contract has a ceiling value of $2,770.74 and a performance period through March 13, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp as the sole prime contractor. The IDC serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) 40 MG/0.4 ML syringes. The $1,971.29 order has a completion date of February 12, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $17,963.62 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA 40 MG/0.8 ML syringes. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of HUMIRA(CF) 20 MG/0.2 ML syringes. The contract is a firm fixed price delivery order with a potential value of $2,770.74 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is part of a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563557780 HUMIRA 40 MG/0.8 ML SYRINGES. The contract has a completion date of February 6, 2024 and a potential value of $3,325.28. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical products to support military treatment programs and facilities. This delivery order is part of a larger...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $6,993.10 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA 40 MG/0.8 ML syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB24FBZCFDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA 40 MG/0.8 ML syringes. The contract, valued at $8,148.80, has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an existing indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for delivering pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order does not have a set-aside designation.
Generated 7/12/24, 10:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 4/12/24 |